CXCL10 and metabolic dysfunction-associated steatohepatitis: Given the fact that liver fibrosis is a marker of disease progression and severity and a consequence of active inflammation and liver injury, we examined the role of CXCL10 in FFC diet-induced NASH related fibrosis.